Week in Review: Cardiologist pay climbs 10% | Energy drinks & heart disease | CMS, FDA propose major change | Treating HFmrEF

Cardiologists in the United States now earn an average annual income of $575,000. That represents an increase of 10% compared to the previous year.

The family of a teenage girl who died unexpectedly in 2025 has sued two energy drink distributors.

The Society of Thoracic Surgeons put together an expert committee to examine the prevention and treatment of new-onset postoperative atrial fibrillation after cardiac surgery. The group shared recommendations for before, during and after treatment.

CMS and the FDA say the goal is to improve patient access to medical devices that address an unmet need.

The FDA asked, and Eli Lilly and Company delivered. The company now hopes to secure an additional approval for orforglipron/Foundayo that covers the treatment of type 2 diabetes.

Pulnovo Medical, a global medtech company, plans on using the funds for clinical development, regulatory submissions, commercialization and much more. 

Gregg Stone, MD, spoke to Cardiovascular Business about the lessons he and his colleagues learned from the STEMI DTU trial.

Conavi Medical's new hybrid imaging system simultaneously performs IVUS and OCT.

Data on the treatment and management of HFmrEF are limited, but a new scientific statement from the Heart Failure Society of America highlights how important it is to take this condition seriously.

The new clinic wants to keep patients out of hospital EDs when possible and provide care at a lower cost.